Clindamycin 300 mg capsules launch
In December, Creo Pharma launched a new strength of Clindamycin capsules. This is the first and only licensed clindamycin 300 mg approved for use in the UK.
For more information, please see the Public Assessment Report by the MHRA where the SPC and leaflet are included.
Posted by Marc on 15/01/13
Tel: +44 (0) 1371 822022
Fax: +44 (0) 1371 822044
Creo Specialist Product Services:
Main Office Enquiries Tel: 0844 879 3188
Emergency Specialist Product Supply
(out of office hours) Tel: 0207 873 2397
Creo Pharma Ltd
Felsted Business Centre
Essex, CM6 3LY